Brief: GlycoMimetics Names Harout Semerjian as New CEO
04/08/2021 21:56
Aug 4 (Reuters) - GlycoMimetics Inc GLYC.O :
* GLYCOMIMETICS NAMES HAROUT SEMERJIAN AS NEW CHIEF
EXECUTIVE
OFFICER TO SUCCEED RETIRING CEO RACHEL KING
* GLYCOMIMETICS INC - KING, COMPANY'S FOUNDING CEO, WILL
REMAIN A
DIRECTOR AND ADVISOR TO SUPPORT TRANSITION
Source text for Eikon: ID:nBw3Cn78va
Further company coverage: GLYC.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Crescent Biopharma
See all newsBrief: Crescent Biopharma - Potential To Initiate First CR-001 Phase 3 Study In Early 2028
Brief: Crescent Biopharma Announces FDA Clearance Of Ind Application For CR-002, A Pd-L1-Targeted Topoisomerase Inhibitor Adc, For The Treatment Of Solid Tumors
Crescent Biopharma posts smaller-than-expected Q2 net loss
U.S. STOCKS ON THE MOVE-Cintas, Veradermics
Crescent Biopharma slips on $125 mln share offering